BioSpace News Archive

Press Releases

Health Canada Approves XEOMIN® (incobotulinumtoxinA) for Treatment of Adults with Post-stroke Lower Limb Spasticity in the Ankle and Foot

December 17, 2024
·
5 min read
Press Releases

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

December 17, 2024
·
1 min read
Press Releases

Akamis Bio Announces $60 Million in Funding Linked to Series A Prime Financing and New Strategic Partnership

December 17, 2024
·
5 min read
Press Releases

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

December 17, 2024
·
8 min read
Press Releases

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761

December 17, 2024
·
4 min read
Press Releases

Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

December 17, 2024
·
8 min read
Press Releases

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

December 17, 2024
·
2 min read
Press Releases

RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine

December 17, 2024
·
2 min read
Press Releases

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery

December 17, 2024
·
6 min read
Press Releases

Akava Therapeutics, Inc. congratulates SAB Chair Dr. Hande Ozdinler, Founder Dr. Richard B. Silverman, and Dr. William Klein on their recent grant of $7.3 million from the National Institute on Aging to investigate AKV9 in neurodegenerative diseases

December 17, 2024
·
2 min read